Objective: Glucocorticoids (GC) are indicated for a number of conditions in obstetrics and perinatal medicine; however, the neurodevelopmental and long-term neurological consequences of early-life GC exposure are still largely unknown. Preclinical studies have demonstrated that GC have a major influence on hippocampal cell turnover by inhibiting neurogenesis and stimulating apoptosis of mature neurons. Here we examined the fate of the limited pool of neural progenitor cells (NPC) after GC administration during neonatal development; the impact of this treatment on hippocampal structure was also studied.
Introduction
Acquisition and loss of hippocampal neurons are implicated in the regulation of cognition, mood and neuroendocrine function. [1] [2] [3] [4] Most likely, the availability of hippocampal neurons determines neuroplastic changes in the intra-hippocampal circuitry as well as connectivity between the hippocampus and other cortical and sub-cortical areas. 5 The subgranular zone (SGZ) of the hippocampal dentate gyrus is endowed with a pool of neural precursor cells (NPC) which can divide and differentiate into either neurons or glial cells. 2, 6 Newly-generated neurons integrate into existing hippocampal circuits 6 and facilitate learning and memory. [2] [3] [4] Neurogenesis tapers off over lifetime and is regulated by intrinsic (e.g. age 7, 9 ) and extrinsic signals (e.g. stress 10, 11 ) whose actions are mainly mediated by GC. Since the size of the NPC pool is a potentially important determinant of life-long hippocampal function, there is considerable interest in the link between lifetime neurogenesis and cognitive deficits that result from exposure to high GC levels. 12, 13 The synthetic glucocorticoid receptor (GR) agonist, dexamethasone (DEX), is commonly used in obstetrics and neonatal medicine. Previously, we demonstrated that DEX induces cell cycle arrest 14 and apoptosis [15] [16] [17] in mature neurons of the dentate gyrus. In this study, we addressed the question of whether DEX can directly influence the survival of NPC. In addition, we tested the hypothesis that neonatal DEX administration permanently depletes the neurogenic pool. Our results show that GC target NPC for apoptosis and that neonatal GC markedly reduces the number of NPC available for the generation of new neurons.
Immunocyto-and histochemistry: Cells or sections were fixed (4% paraformaldehyde), permeabilized (0.3% Triton-X100/PBS), blocked and incubated (4 o C) with anti-BrdU (after treatment with 2 N HCl), nestin (1:1000; Millipore, Goettingen, Germany), -TuJ1 (1:500; Babco, Richmond, CA), -MAP2 (1:500; Sigma), -doublecortin (1:500; Santa Cruz, Heidelberg, Germany), -GFAP (1:1500; DAKO or 1:4,000, Sigma), -NeuN (1:500; Millipore), -O4 (1:500; Millipore), -GR (1:300; M20, Santa Cruz), -Sox2 ( 1A) . Immunoreactive GR was detectable in NPC and immature/young neurons (Fig 1B and Fig. 1C ).
Results

Phenotypic identity and GR expression in hippocampal cultures
GR expression was observed in ~45% of nestin-GFP-transfected NPC and ~65% of Tα-tubulin-GFP labeled immature neurons ( Fig 1B) ; stimulation with DEX resulted in translocation of immunoreactive GR to the nucleus, suggestive of its transcriptional potential (Fig 1B, inset) . Treatment of cultures with DEX resulted in a dose-dependent induction of apoptosis that was preventable by pre-treatment with the GR antagonist RU38486 ( Fig 1D) ; since consistently robust effects were observed at a dose of 10 -5 M, this dose was chosen for all subsequent in vitro experiments.
Regulation of NPC and post-mitotic hippocampal cell fate by GC
Neuroplasticity depends on the availability of NPC. 6 While neurogenesis is implicated in recovery from stroke, 22 reduced proliferative capacity of hippocampal cells is associated with epilepsy, 23 impaired 24, 25 We show here that DEX reduces the number of immunocytochemically identified NPC (by ~39%), neuroblasts (~39%) and immature neurons (~54%) (P < 0.05, in all cases; Fig. 2A ).
We previously demonstrated that GC induce apoptosis in hippocampal cells in culture 16, 17 and that GC-induced apoptosis in situ is prominent in the SGZ where NPC reside and proliferate. 21, 26 To examine the hypothesis that apoptosis leads to a reduction in NPC and immature neuron numbers, we next treated hippocampal cultures with the cytosine analog bromodeoxyuridine (BrdU, to reveal recently proliferated cells 27 ) and DEX for 24 h before quantifying apoptosis (identified by TUNEL or activated caspase 3 immunoreactvity) in recently-proliferated (BrdU-labeled 27 ) cells. As compared to untreated cells (Fig 2B1-2B5 ), DEX-treated cells showed greater co-localization of BrdU and TUNEL signals (Fig   2C1-2C5) . Evaluation of individual merged images revealed significantly increased apoptosis among both mitotic (BrdU + : CON: 8.4 ± 3.4%; DEX: 17.8 ± 5.0%; P < 0.05) and resting (BrdU -: CON: 27.6 ± 3.0%; DEX: 41.0 ± 4.1%; P < 0.05) cell populations after GC treatment (Fig 2D) . The results obtained with TUNEL histochemistry were corroborated by cleaved (activated) caspase 3 immunocytochemistry (Fig 2E) .
Phenotype-specificity of the apoptotic actions of GC NPC proliferate and differentiate along either neuronal or glial lineages. 6 Given the intrinsic characteristics of NPC and the heterogeneous nature of primary hippocampal cultures (Fig 1) , we here analyzed the cell phenotypes targeted for GC-induced apoptosis in mixed hippocampal cultures transfected with specific plasmids that would facilitate distinction between NPC (nestin-EGFP) and neuronal progenitors (Tα1-GFP). Exposure of cells to DEX produced a significant increase in TUNEL-labeled apoptotic cells among the NPC (Fig 3A- C, 3G-I and 3U; P < 0.05) and neuronal progenitor (Fig 3D-F , 3J-L and 3U; P < 0.05) cell populations; the TUNEL results were confirmed by staining for cleaved (activated) caspase 3 immunoreactivity (Fig 3M-P , 3Q-T and 3V; P < 0.05). In all cases, the apoptotic actions of DEX were attenuated when cells were pre-treated with the GR antagonist RU 38486, indicating their mediation by GR (Fig 3U, 3V) . Interestingly, astrocytes marked with GFAP-GFP did not succumb to the apoptotic effects of DEX (Fig 3U) .
Mitochondrial mechanisms mediate GC-induced apoptosis in NPC
The data showing that DEX treatments leads to an activation of caspase 3 ( Fig 2E, Fig 3M-3T , 3U, 3V, and Fig 5B-D) in NPC hinted at involvement of the mitochondrial or 'instrinsic' pathway of apoptosis. 15 These findings were confirmed in hippocampal cultures using pharmacological inhibitors of caspase 3 and its upstream caspase, caspase 9 ( Fig 4A) . Examining events upstream of the caspases, we observed that DEX treatment dose-dependently increases the ratio of pro-apototic bax to anti-apoptotic bcl-2 mRNA expression, without influencing the bax:bcl XL mRNA expression ratio ( Fig 4B) ; the latter findings are consistent with the fact that the predominant anti-apoptotic protein in developing neurons is Bcl-2 rather than Bcl XL . 26 The mitochondrial proteins Bax and Bcl-2 act in a rheostatic manner to regulate the integrity of the mitochondrial permeability transition which is particularly sensitive to perturbation by reactive oxygen species (ROS). Measurement of ethidium intercalation into DNA showed that ROS generation represents a mechanism through which DEX induces apoptosis (Fig 4C) . Additionally, DEX stimulates ROS production in NPC (Fig 4D and Fig 4E) ; this effect is accompanied by a translocation of membrane-associated p47 phox (an essential component of the nicotinamide adenine dinucleotide phosphate [NADPH] oxidase [Nox] complex required for the production of superoxide anions) (Fig 4F) and reductions in the activities of Cu ++ /Zn ++ superoxide dismutase and glutathione, two key anti-oxidant enzymes (Fig 4G) .
Depletion of the NPC pool by GC treatment during peak neurogenesis in vivo
Hippocampal neurogenesis occurs at a high frequency during early postnatal life. 28 However, NPC have limited self-renewal capacity 29 and the NPC pool from which new neurons are generated diminishes exponentially with age; 7, 9 GC are thought to at least partially contribute to the latter phenomenon. 8 On the other hand, proliferating hippocampal cells were previously reported to express GR only sparsely. 30 As shown in Fig 5A , numerous cells in the neonatal dentate gyrus express GR along a gradient that increases from the SGZ to the inner layers of the GCL where more mature granule neurons are localized. Importantly, DEX treatment provoked a 60% increase in apoptosis (increase in active caspase 3 immunoreactivity) in the SGZ (Fig 5B-D ; P < 0.05). Two types of NPC are found in the SGZ: quiescent neural precursors (QNP; GFAP-positive, proliferate relatively slowly) and amplifying neural precursors (ANP; GFAP-negative, display high proliferative activity). 31 Accordingly, it was considered important to investigate if QNP and ANP might be differentially sensitive to glucocorticoids.
Both QNP and ANP express nestin and Sox2, but whereas nestin levels in ANP diminish over time, Sox2 expression is maintained at relatively steady levels in both NPC subtypes and serves as a more reliable marker of NPC (QNP: GFAP+/Sox2+; ANP: GFAP-/Sox2+). Exploiting these characteristics, co-localization studies showed that a similar proportion of QNP and ANP express GR (Suppl Fig   S1A-S1C ), suggesting their similar vulnerability to DEX.
We subsequently assessed the impact of neonatal GC administration on the proliferative capacity of the dentate gyrus in later life by performing stereological counts of the number of BrdU-and Ki67-stained cells in the SGZ of PND10, 18 and 28 days (Fig 6A-C) . The results of this analysis revealed that neonatal treatment with DEX results in a significant reduction in the number of cells available for mitosis at any given time (P < 0.05; Fig 6D) , suggesting a depletion of the NPC pool by neonatal DEX. Interestingly, the absolute differences between the number of proliferating cells in the SGZ of both control and DEX-treated rats diminished over time (but remained significantly different),
probably reflecting age-related decreases in proliferative activity (Fig 6D) and the fact that a sub-population of NPC that do not express GR (see Suppl Fig S1) may escape the apoptotic actions of neonatal GC treatment.
Since expansion of the GCL occurs primarily during early postnatal life, we next carried out a stereological assessment of the volumes of the SGZ and GCL. This analysis revealed that SGZ volumes of DEX-treated animals were significantly smaller (P < 0.05), despite similar volumetric increments over time (14-20%) ( Fig 6E) ; the latter suggests proliferation by residual NPC that were spared from the apoptotic effects of neonatal DEX. While both controls and DEX-treated animals showed significant increases in the volumes of their GCL between the ages of 10 and 28 days (Fig 6E, P < 0.05), GCL volumes in the DEX-treated animals were significantly smaller than in controls (Fig 6E, P < 0.05). In sum, these results suggest that reduced neurogenesis and subsequently, reduced cell acquisition in the GCL, result in a marked retardation of GCL development in animals exposed to neonatal DEX (Fig 6E) .
Discussion
Several neurological and psychiatric disorders are hallmarked by hippocampal dysfunction. The last decade has witnessed compelling evidence for a link between hippocampal function and cell turnover in the postnatal hippocampus. 6, 13, 24, 25, 32 Neuronal turnover in the hippocampus is a dynamic process involving neurogenesis and apoptosis in the germinative layer (SGZ) of the dentate gyrus; 3 stress and elevated GC levels inhibit neurogenesis and stimulate apoptosis in the hippocampus. 11, 12, 21, 26 While GC are known to interfere with the neural cell cycle, 14 it is not known whether GC target NPC for apoptosis. Accordingly, we here examined the incidence of apoptosis in hippocampal cultures that were genetically marked with developmental phase-specific markers to identify proliferating multipotent NPC and NPC destined to become neurons. In addition, we studied the consequences of neonatal treatment with DEX, a synthetic GC (when neurogenesis and apoptosis occur at high frequency 28 ) on dentate gyrus development in situ.
The presented results demonstrate that both NPC and neuronal progenitors are subject to DEX-induced apoptosis. The actions of DEX were shown to be mediated by GR which are expressed by NPC, neuronal progenitors and mature neurons (in culture) and by QNP and ANP cells residing in the SGZ; notably, the SGZ displays a prominent apoptotic response to DEX. It is important to note, however, that since GR expression by NPC is not ubiquitous, a sub-population of NPC may be (at least transiently)
spared from the actions of DEX. However, given the finite self-renewing properties of NPC, 29 disruption of the lifelong cycle of neuronal birth and therefore, sustained deleterious effects on hippocampal growth and function, is a plausible scenario being investigated in a long-term study. Meanwhile, analysis of the mechanisms through which DEX induces NPC apoptosis revealed a role for the mitochondrial pathway. Consistent with previous findings, 33 our results indicate that the pro-apoptotic Thus, the hippocampus undergoes its most dynamic structural organization during the early postnatal period, with a precipitous depletion of the NPC pool 9 that probably reflects changes in the milieu that normally encourages NPC proliferation. 35 Given that NPC are vulnerable to the apoptotic actions of DEX (this study),and have a limited capacity for self-renewal, 29 as well as the fact that the dentate gyrus increases in neuronal number and volume for at least 1 year, 36 it was considered important to examine whether DEX influences the in vivo NPC pool in a transient or sustained fashion. We observed that neonatal DEX treatment induces a sustained reduction in the number of mitotic cells and, importantly, retards the volumetric growth of the SGZ and GCL. This finding is consistent with previous reports in rats and rhesus monkeys. [37] [38] [39] On the other hand, postnatal neurogenesis and granule cell volumes appear to be unaltered by prenatal exposure to DEX 40 and neurogenesis is only transiently inhibited when DEX is administered to adults. 41 These observations suggest that early postnatal life may represent a window during which NPC are particularly sensitive to DEX and that exposure to DEX during this period results in a protracted retardation of dentate gyrus development.
The paradigm of chronic DEX administration during perinatal life is clinically relevant; there is convincing evidence that glucocorticoids during early childhood lead to impairments of neuromotor functions and cognition, as well as head and somatic growth . 42, 43 This study shows that the hippocampus endures increased levels of neuronal apoptosis, retarded growth and sustained reductions in the rate of neurogenesis when DEX is administered during neonatal life; moreover, an earlier study associated such treatment with reduced forebrain expression of synaptic proteins and disruption of the ontogeny of neurotransmitter systems. 37 Since lifetime cognitive performance relies on plasticity (including neurogenesis) in the hippocampus, 2, 4, 6, 34 the sustained depletion of the NPC pool by neonatal DEX is likely to have a major impact on lifetime learning and memory. Lastly, early-life experiences that stimulate endogenous glucocorticoid secretion and interfere with neuroplasticity are established etiopathogenic factors in a number of psychiatric conditions, best exemplified by major depression.
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Titles and legends to figures The volume of the SGZ and GCL of rats exposed to DEX on PND1-7 is significantly smaller when estimated on PND10 and 28. Note that the increase in GCL volume, between PND10 and PND28, was greater in controls than in neonatally DEX-treated rats. All numerical values are mean ± SEM. * P < 0.05, ** P <0.01, as compared to age-matched controls; ## indicates significant difference between P10 and P28 (P< 0.01). PND10, CON, n=7; DEX, n=8; PND 18, CON, n=8,; DEX, n=8; PND28, CON, n=8; DEX, n=9. Scale bar: 20 µm. The volume of the SGZ and GCL of rats exposed to DEX on PND1-7 is significantly smaller when estimated on PND10 and 28. Note that the increase in GCL volume, between PND10 and PND28, was greater in controls than in neonatally DEX-treated rats. All numerical values are mean ± SEM. * P < 0.05, ** P <0.01, as compared to age-matched controls; ## indicates significant difference between P10 and P28 (P< 0.01). PND10, CON, n=7; DEX, n=8;
